ArticleACS omega2018

Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders.

S Shashidhar Bharadwaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.